CBRE Secures First Major Lease of 2025 at Seattle Life Science Facility
CBRE has arranged a 31,837-square-foot lease for UW Medicine’s Institute for Protein Design (IPD) at 330 Yale, a 211,555-square-foot life science building located in Seattle’s South Lake Union neighborhood. Marking the first major life sciences lease of 2025, the deal signals strong demand in the region’s biotech sector.
Paul Carr, Marcus Yamamoto, and Katie Smith of CBRE represented the property owner, 330 Yale Owner LLC, a subsidiary of KKR-managed accounts. Lincoln Property Company serves as the property manager.
“This new lease is a testament to the strength of Seattle’s life science ecosystem,” said Marcus Yamamoto of CBRE. “The Institute will occupy the entire third floor, and the property can accommodate future growth with pre-built lab space available on the second floor.”
Since acquiring the asset last year, 330 Yale Owner LLC has made significant strategic investments in the facility, adding amenities such as a large conference room, rooftop event space, and move-in ready lab suites.
“In this competitive Seattle life science market, we couldn’t be more pleased that a leader such as the IPD has chosen to expand into 330 Yale,” added Sam Gillespie, Vice President at K-Star Asset Management.
Photo credit: Mark Griffith Photography.
